4-chloro-3'-trifluoromethyl benzophenone | 91503-65-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-chloro-3'-trifluoromethyl benzophenone
• 英文别名: (4-chlorophenyl)(3-trifluoromethylphenyl)methanone；(4-Chlorophenyl)[3-(trifluoromethyl)phenyl]methanone；(4-chlorophenyl)-[3-(trifluoromethyl)phenyl]methanone
• CAS: 91503-65-0
• 化学式: C₁₄H₈ClF₃O
• mdl: MFCD12653585
• 分子量: 284.665
• InChiKey: PGDKPDCUHKYHOS-UHFFFAOYSA-N

物化性质

• 沸点：
  347.6±42.0 °C(Predicted)
• 密度：
  1.336±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.071
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-溴吡啶 、 4-chloro-3'-trifluoromethyl benzophenone 在 正丁基锂 作用下， 以 乙醚 、 正己烷 、 四氢呋喃 为溶剂， 反应 2.0h， 以16%的产率得到(4-chlorophenyl)(3-trifluoromethylphenyl)pyridin-3-yl methanol
  参考文献：
  名称：

  Analogues of Fenarimol Are Potent Inhibitors of Trypanosoma cruzi and Are Efficacious in a Murine Model of Chagas Disease

  摘要：

  We report the discovery of nontoxic fungicide fenarimol (1) as an inhibitor of Trypanosoma cruzi (T. cruzi), the causative agent of Chagas disease, and the results of structure-activity investigations leading to potent analogues with low nM IC(50)s in a T. cruzi whole cell in vitro assay. Lead compounds suppressed blood parasitemia to virtually undetectable levels after once daily oral dosing in mouse models of T. cruzi infection. Compounds are chemically tractable, allowing rapid optimization of target biological activity and drug characteristics. Chemical and biological studies undertaken in the development of the fenarimol series toward the goal of delivering a new drug candidate for Chagas disease are reported.

  DOI：

  10.1021/jm2015809
• 作为产物：
  描述：

  3-三氟甲基苯甲酸 在 氯化亚砜 、 dihydrogen dichloro-bis(di-tert-butylphosphinito-κP)palladium(2-) 、 potassium carbonate 作用下， 以 1,4-二氧六环 、 甲苯 为溶剂， 反应 2.0h， 生成 4-chloro-3'-trifluoromethyl benzophenone
  参考文献：
  名称：

  Analogues of Fenarimol Are Potent Inhibitors of Trypanosoma cruzi and Are Efficacious in a Murine Model of Chagas Disease

  摘要：

  We report the discovery of nontoxic fungicide fenarimol (1) as an inhibitor of Trypanosoma cruzi (T. cruzi), the causative agent of Chagas disease, and the results of structure-activity investigations leading to potent analogues with low nM IC(50)s in a T. cruzi whole cell in vitro assay. Lead compounds suppressed blood parasitemia to virtually undetectable levels after once daily oral dosing in mouse models of T. cruzi infection. Compounds are chemically tractable, allowing rapid optimization of target biological activity and drug characteristics. Chemical and biological studies undertaken in the development of the fenarimol series toward the goal of delivering a new drug candidate for Chagas disease are reported.

  DOI：

  10.1021/jm2015809

文献信息

• Poly(ethylene glycol) dimethyl ether mediated oxidative scission of aromatic olefins to carbonyl compounds by molecular oxygen
  作者：Tao Yu、Mingqing Guo、Simiaomiao Wen、Rongrong Zhao、Jinlong Wang、Yanli Sun、Qixing Liu、Haifeng Zhou

  DOI：10.1039/d1ra02007b

  日期：——

  A simple, and practical oxidative scission of aromatic olefins to carbonyl compounds using O2 as the sole oxidant with poly(ethylene glycol) dimethyl ether as a benign solvent has been developed. A wide range of monosubstituted, gem-disubstituted, 1,2-disubstituted, trisubstituted and tetrasubstituted aromatic olefins was successfully converted into the corresponding aldehydes and ketones in excellent

  已经开发了一种使用 O 2作为唯一氧化剂，聚（乙二醇）二甲醚作为良性溶剂，将芳族烯烃氧化裂解为羰基化合物的简单实用的方法。即使在克级反应中，多种单取代、偕二取代、1,2-二取代、三取代和四取代芳族烯烃也能以优异的收率成功转化为相应的醛和酮。还进行了一些对照实验以支持可能的反应途径。
• 一种烯烃氧化制备醛酮类化合物的方法
  申请人：三峡大学

  公开号：CN112608222A

  公开（公告）日：2021-04-06

  本发明提供了一种烯烃氧化制备醛酮类化合物的方法，涉及的制备方法为氧气参与的烯烃氧化裂解反应，具体步骤如下：在溶剂与氧化剂存在的条件下，将烯烃原料氧化裂解制得相应的醛酮类产物。与传统方法相比，本发明不需要加入任何催化剂或配体，也不需要使用高压氧气，具有反应条件简单温和、绿色环保、成本低、原子经济性高等优点，而且底物适应范围广，产率高，在合成醛酮类医药中间体和化工原料方面具有广阔的应用前景。
• Analogues of Fenarimol Are Potent Inhibitors of Trypanosoma cruzi and Are Efficacious in a Murine Model of Chagas Disease
  作者：Martine Keenan、Michael J. Abbott、Paul W. Alexander、Tanya Armstrong、Wayne M. Best、Bradley Berven、Adriana Botero、Jason H. Chaplin、Susan A. Charman、Eric Chatelain、Thomas W. von Geldern、Maria Kerfoot、Andrea Khong、Tien Nguyen、Joshua D. McManus、Julia Morizzi、Eileen Ryan、Ivan Scandale、R. Andrew Thompson、Sen Z. Wang、Karen L. White

  DOI：10.1021/jm2015809

  日期：2012.5.10

  We report the discovery of nontoxic fungicide fenarimol (1) as an inhibitor of Trypanosoma cruzi (T. cruzi), the causative agent of Chagas disease, and the results of structure-activity investigations leading to potent analogues with low nM IC(50)s in a T. cruzi whole cell in vitro assay. Lead compounds suppressed blood parasitemia to virtually undetectable levels after once daily oral dosing in mouse models of T. cruzi infection. Compounds are chemically tractable, allowing rapid optimization of target biological activity and drug characteristics. Chemical and biological studies undertaken in the development of the fenarimol series toward the goal of delivering a new drug candidate for Chagas disease are reported.